Lin Qiu1, Xia Liu1, Meng Xiao2, Jing Xie3, Wei Cao3, Zhengyin Liu3, Abraham Morse4, Yuhua Xie5, Taisheng Li3, Lan Zhu1. 1. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China. 2. Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China. 3. Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China. 4. Department of Obstetrics and Gynecology, Tufts University Medical School, Boston, Massachusetts, USA. 5. Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Abstract
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spread mainly through respiratory droplets or direct contact. However, the infection condition of the genital system is unknown. Our aim in this study was to determine if SARS-CoV-2 is present in the vaginal fluid of women with coronavirus disease 2019 (COVID-19). METHODS: Ten women with confirmed severe COVID-19 pneumonia admitted to the Tongji Zhongfa Hospital intensive care unit from 4 February 2020 through 24 February 2020 were included. Clinical records, laboratory results, and computed tomography examinations were retrospectively reviewed. The potential for genital infection was accessed by testing for the presence of SARS-CoV-2 in vaginal fluids obtained from vaginal swab samples. Reverse transcriptase polymerase chain reaction was used to confirm the SARS-CoV-2 infection in vaginal fluids. RESULTS: The clinical characteristics of the 10 women were similar to those reported in other severe COVID-19 patients. All 10 patients were tested for SARS-CoV-2 in vaginal fluid, and all samples tested negative for the virus. CONCLUSIONS: Findings from this small group of cases suggest that SARS-CoV-2 virus does not exist in the vaginal fluids of severe COVID-19 patients.
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spread mainly through respiratory droplets or direct contact. However, the infection condition of the genital system is unknown. Our aim in this study was to determine if SARS-CoV-2 is present in the vaginal fluid of women with coronavirus disease 2019 (COVID-19). METHODS: Ten women with confirmed severe COVID-19 pneumonia admitted to the Tongji Zhongfa Hospital intensive care unit from 4 February 2020 through 24 February 2020 were included. Clinical records, laboratory results, and computed tomography examinations were retrospectively reviewed. The potential for genital infection was accessed by testing for the presence of SARS-CoV-2 in vaginal fluids obtained from vaginal swab samples. Reverse transcriptase polymerase chain reaction was used to confirm the SARS-CoV-2 infection in vaginal fluids. RESULTS: The clinical characteristics of the 10 women were similar to those reported in other severe COVID-19 patients. All 10 patients were tested for SARS-CoV-2 in vaginal fluid, and all samples tested negative for the virus. CONCLUSIONS: Findings from this small group of cases suggest that SARS-CoV-2 virus does not exist in the vaginal fluids of severe COVID-19 patients.
Authors: Hans Johnson; Megha Garg; Saran Shantikumar; Jecko Thachil; Bhavan Rai; Omar M Aboumarzouk; Hashim Hashim; Joe Philip Journal: Turk J Urol Date: 2021-03-01
Authors: Selcan Sinaci; Doga F Ocal; Banu Seven; Ali T Anuk; Berhan Besimoglu; Mehmet C Keven; Sule Goncu Ayhan; Mustafa S Akin; Cuneyt Tayman; Huseyin L Keskin; Elif G Yapar Eyi; Bedia Dinc; Ozlem Moraloglu Tekin; Dilek Sahin Journal: J Med Virol Date: 2021-06-12 Impact factor: 20.693
Authors: Aprine Tan; Keng Lin Wong; Hamid Rahmatullah Bin Abd Razak; Biauw-Chi Ong; Merng Koon Wong Journal: Singapore Med J Date: 2022-07 Impact factor: 3.331
Authors: Estelle Morau; Lionel Bouvet; Hawa Keita; Florence Vial; Marie Pierre Bonnet; Martine Bonnin; Agnès Le Gouez; Dominique Chassard; Frédéric J Mercier; Dan Benhamou Journal: Anaesth Crit Care Pain Med Date: 2020-05-13 Impact factor: 4.132